EXCLUSIVE: Psychedelics Co. To Get Up To $7.5M In Financing - Here's Its Secret To Raising Millions In A Tough Environment
Portfolio Pulse from Javier Hasse
Psyched Wellness, a life sciences company focused on wellness products derived from the Amanita Muscaria mushroom, has secured a capital infusion of up to $7.52 million from cannabis investment firm Gotham Green Fund III. The investment will be used to facilitate the nationwide rollout of products centered around Psyched Wellness's proprietary extract, AME-1. The agreement also provides Gotham Green with the right to nominate board members.
September 01, 2023 | 4:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Psyched Wellness has secured a significant investment from Gotham Green Fund III, which will be used to facilitate the nationwide rollout of its wellness products. This could potentially increase the company's market share and revenues.
The investment from Gotham Green Fund III will allow Psyched Wellness to expand its product distribution nationwide, potentially increasing its market share and revenues. Additionally, the right of Gotham Green to nominate board members could lead to strategic decisions that further benefit the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100